Home
About
Overview
Sharing Data
ORCID
Help
History (9)
The population genetics of the origin and divergence of the Drosophila simulans complex species.
Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participants.
Selective inhibition of the carotid body sensory response to hypoxia by the substance P receptor antagonist CP-96,345.
Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment.
Infliximab as first-line therapy for severe Crohn's disease?
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Infliximab as first-line therapy for severe Crohn's disease?
Infliximab as first-line therapy for severe Crohn's disease? Inflamm Bowel Dis. 2002 Jan; 8(1):58-9; discussion 63-5.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Crohn Disease
Gastrointestinal Agents
Humans
Infliximab
Severity of Illness Index
authors with profiles
Russell D. Cohen